Cannabis extract outperformed pure CBD at reducing brain immune cell inflammation through multiple molecular pathways

What the researchers found

The cannabis extract significantly reduced pro-inflammatory cytokines IL-1β, IL-6, and TNF-α in activated microglia, while pure CBD only partially reduced them and beta-caryophyllene was ineffective. The extract's effects were only partially dependent on CB2 receptors and also involved regulation of endocannabinoid-metabolizing enzymes, inhibition of reactive oxygen species, and suppression of NF-κB nuclear translocation via JNK/p38 modulation.

Why it matters

This study provides molecular evidence for why whole cannabis extracts may be more effective than isolated CBD for neuroinflammation, supporting the entourage effect hypothesis with specific mechanistic data.

The numbers in context

The extract significantly attenuated IL-1β, IL-6, and TNF-α upregulation. CBD only partially attenuated these markers. Beta-caryophyllene (a common cannabis terpene) was completely ineffective alone.

How the study worked

BV-2 microglial cells were pretreated with a CBD-and-terpene-enriched cannabis extract, pure CBD, or beta-caryophyllene, then stimulated with LPS (lipopolysaccharide) to induce inflammation. Multiple inflammatory pathways and signaling cascades were measured.

What this study cannot tell us

In vitro study using a cell line, not primary microglia or whole-brain tissue. The specific extract composition may not represent all commercial products. Concentrations used may not reflect achievable brain levels. No in vivo validation.

How to read the evidence

Mechanistically detailed in vitro study, but cell line results may not translate to whole-organism effects.

When this study was published

Published in 2022.

The bigger picture

Neuroinflammation is implicated in conditions from Alzheimer's to depression. If whole cannabis extracts are more effective than isolated cannabinoids at controlling brain inflammation, this has implications for how cannabis-based neurotherapeutics are developed.

Questions still open

• Which specific terpenes in the extract contribute to the enhanced anti-inflammatory effect? Would this advantage translate to clinical outcomes in neuroinflammatory diseases? Can the optimal cannabinoid-terpene ratio be identified?

Common questions

Read the original research

Non-psychotropic Cannabis sativa L. phytocomplex modulates microglial inflammatory response through CB2 receptors-, endocannabinoids-, and NF-κB-mediated signaling.

Phytotherapy research : PTR, 36(5), 2246-2263

Citation

Borgonetti, Vittoria; Benatti, Cristina; Governa, Paolo; Isoldi, Giovanni; Pellati, Federica; Alboni, Silvia; Tascedda, Fabio; Montopoli, Monica; Galeotti, Nicoletta; Manetti, Fabrizio; Miraldi, Elisabetta; Biagi, Marco; Rigillo, Giovanna. (2022). Non-psychotropic Cannabis sativa L. phytocomplex modulates microglial inflammatory response through CB2 receptors-, endocannabinoids-, and NF-κB-mediated signaling.. Phytotherapy research : PTR, 36(5), 2246-2263. https://doi.org/10.1002/ptr.7458

Explore the wider topic

• CBD Oil Quality Guide: How to Avoid Snake Oil
• Anxiety After Quitting Weed: When to Consider Medication
• Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
• Cannabis for Chronic Pain: What the Research Actually Supports
• Cannabis and Epilepsy: The Epidiolex Story and What It Means
• Does CBD Actually Work for Anxiety? What the Evidence Shows
• Does CBD Help with Weed Withdrawal? What Studies Show
• CBD vs THC: The Differences That Actually Matter
• The Proven Medical Benefits of Cannabis: What Research Supports
• Quitting Weed Before Surgery
• Weed and Medications: What Changes When You Quit
• Quitting Weed During Pregnancy: What You Need to Know
• Quitting Weed While Pregnant: What You Need to Know
• Cannabis and Older Adults: Risks Seniors Should Know
• Cannabis and Breastfeeding: THC in Breast Milk